Biophotonics Discovery
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Artificial Intelligence
Q3
└
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q3
└
Medicine (miscellaneous)
Q3
Publisher
SJR 2025
0.278
Q3
SJR Score
H-Index
4
Citations / Doc (2yr)
1.21
Total Docs. (latest)
23
Total Citations (3yr)
17
Publication type
Journals
ISSN
30054745
Coverage
2024-2025
Journal Rank
#18,013
Subject Categories
Artificial Intelligence
Q3
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q3
Medicine (miscellaneous)
Q3
Radiology, Nuclear Medicine and Imaging
Q3
Biomedical Engineering
Q4
Detailed Metrics
| Total Docs. (latest) | 23 |
| Total Docs. (3 years) | 14 |
| Total Refs. | 1,210 |
| Total Citations (3 years) | 17 |
| Citable Docs. (3 years) | 13 |
| Citations / Doc. (2 years) | 1.21 |
| Ref. / Doc. | 52.61 |
| % Female | 42.0% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Biophotonics Discovery?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Biophotonics Discovery has an SJR of 0.278 and is ranked Q3.
What is the SJR and quartile of Biophotonics Discovery?
Biophotonics Discovery has an SJR (SCImago Journal Rank) of 0.278 and its best quartile is Q3.
What is the H-index of Biophotonics Discovery?
The H-index of Biophotonics Discovery is 4, meaning 4 of its articles have each been cited at least 4 times.
Is Biophotonics Discovery indexed in Scopus?
Yes. Biophotonics Discovery is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.